INTRODUCTION
In recent years, it has become very difficult to access varieties of microorganisms found in tropical rain forests due to the Convention on Biological Diversity (CBD). Malaysian tropical rain forests have remarkable diversity in flora as well as fauna. It has been reported that there are over 15,000 known species of flowering plants, 286 species of mammals and over 4,000 species of marine fishes 1) . However, no substantial research on microbiological diversity has been carried out here in Malaysia.
Nimura Genetic Solutions Co. Ltd. (NGS), a Japanese bio-prospecting company, is now striving for drug discovery from microbial secondary metabolites of soil microorganisms in Malaysian tropical rain forests.
Our goal is to establish a system which provides fair benefit sharing for Malaysia and Japan under CBD, thus contributing to the societies of both countries.
Collaboration between FRIM and NGS
In We initiated a research project in bio-prospecting for new medicines from tropical rain forests with an emphasis on screening soil microbes which produce bioactive compounds. Through this exclusive agreement, NGS will transfer practical and latest technologies in the screening of useful microbes to FRIM and the local bioindustry. To achieve this, NGS Biological Resources Exploratory Laboratory was opened in one of the FRIM buildings in October, 2002. The transfer of basic technologies for isolation and fermentation of soil actinomycetes was completed in March, 2003, and weekly basis of fermentation screening had been initiated since last April. The fungal isolates are also being investigated in collaboration with FRIM staff. If new active compounds are discovered, NGS will worldwidely arrange co-development with pharmaceutical companies.
Isolation and Characterization of Microorganisms
We mainly use Modified Bennett's Agar (MBA), Humic acid-Vitamin B Agar (HVA) and Bacto Actinomycete Isolation Agar (AIA) for isolation studies. Nystatin and cycloheximide, and nalidixic acid are also employed to eliminate fast-growing fungal and bacterial strains. Colonies, which resembled actinomycetes, were picked out and purified on MBA. During the purification process, morphologically multiplicative strains are eliminated. The obtained strains were kept on MBA slants and applied to secondary metabolite production and cryophilic storage at −80 °C. The fermentation broths were extracted with an organic solvent mixture and then tested for antibacterial and antifungal activity.
In our laboratory, the actinomycete isolates were classified into 5 groups based on their morphological differences on MBA slants (Fig. 1) . For example, 764 actinomycete strains were isolated from 31 soil samples collected in the forest area of FRIM. Further 373 strains were also isolated from 6 different soils which were collected at suburban private property in Malaysia. The diversity of these strains is summarized in Fig. 2 . It was observed that a lower percentage of the typical Streptomyces were isolated from MBA (15.2%) and HVA (8.8%) compared to AIA (22-31%), which is seemingly lower than that described for Japanese soils 2) . In contrast, a higher percentage of oligosporic actinomycetes (33-43%) were observed in all the Malaysian soils so far tested. Photos of some of the oligosporic strains are presented in Fig. 3 .
By the end of August, 2003, the weekly fermentation screening was conducted using 968 isolates, out of which 275 (28.4%) and 161 (16.6%) strains showed antimicrobial activity against Staphylococcus aureus 209P and Saccharomyces cerevisiae ATCC, respectively. Among these hits, 88 strains produced both antibacterial and antifungal activity. Active extracts were subjected to HPLC analysis for comparison with known antibiotics in our data library. Some of them were identified as known antibiotics based on uv spectral date, as shown in Table 1 .
CONCLUSION
NGS has established a good working relationship with FRIM for prospecting soil microorganisms in tropical rain 54 
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Keiichi Numata* and Satoshi Nimura Nimura Genetic Solutions Co. Ltd., 2-10-2, Sendagaya, Shibuya-ku, Tokyo 151-0051, Japan (Received Oct. 17, 2003) forests in Malaysia. Our business model fits the CBD concept and is highly respected in the Malaysian society 3) . We endeavored to perform our research in conformity with Malaysian domestic law related to the CBD.
In the research area, we have already isolated over 2,500 actinomycete strains and screened 968 strains for antibiotic activity. One of the antibacterial hits showed activity against MRSA, and the producer seems to belong to the genus Nonomuraea by the sequence analysis of the 16S rDNA. This active component obtained is suspected to be a new antibiotic, because its UV spectrum and HPLC did not match with any antibiotic ones in our data library. Consequently, we can continue isolation, fermentation, antimicrobial screening and further study of unidentified, active compounds with high expectations for discoveries of new activity among the actinomycete strains from Malaysian soils.
